Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
about
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patientsOral versus intravenous antibiotic treatment for febrile neutropenia in cancer patientsThere should be no ESKAPE for febrile neutropenic cancer patients: the dearth of effective antibacterial drugs threatens anticancer efficacyPrognostic factors for risk stratification of adult cancer patients with chemotherapy-induced febrile neutropenia: a systematic review and meta-analysis.Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia.Management of febrile neutropenia: ESMO Clinical Practice Guidelines.Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlaTreating low-risk febrile neutropenia: Jenny's storyThe evolution towards ambulatory and day-case management of febrile neutropenia.Variation in Management of Fever and Neutropenia Among Pediatric Patients With Cancer: A Survey of Providers in Michigan.Early warning and prevention of pneumonia in acute leukemia by patient education, spirometry, and positive expiratory pressure: A randomized controlled trial.Oral versus intravenous antibiotics in treatment of paediatric febrile neutropenia.Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.Health-related quality of life anticipated with different management strategies for febrile neutropenia in adult cancer patients.Comparison of piperacillin tazobactam and cefoperazone sulbactam monotherapy in treatment of febrile neutropenia.Comparison of two oral regimens for the outpatient treatment of low-risk cancer patients with chemotherapy-induced neutropenia and fever: ciprofloxacin plus cefuroxime axetil versus ciprofloxacin plus amoxicillin/clavulanate.Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.Management of cancer pain: ESMO Clinical Practice Guidelines.Quality assuring adult anti-microbial guidelines.
P2860
Q24197538-58598C1A-69F5-46A5-931F-5E8E7069BA66Q24246096-9F1B6FBA-F56B-4FF7-A602-872BFC88FD74Q27005826-618B55A0-C7E1-4815-9C53-122856EB1CB3Q33412051-EAD17D70-F8FE-4193-B441-E4FF595BB201Q34583481-92C2E0E4-B0F0-4ECC-A497-A96F1F285CFEQ34620670-ADDF919E-E976-4C82-8F00-6196B3C41444Q35077317-67F4E4E7-E65A-485F-B891-114F3CAF4EECQ36153867-1089AE5F-C85D-4D37-BA45-2160C4F2F1C2Q36573955-4204BD4F-DA60-479F-9284-FB1C22255704Q36727621-5F53D1DF-789D-4600-9BFC-46DFB7D2EFBEQ37345664-EFA0FC3E-5600-4C6C-960F-DBA350F01125Q37963923-97E4BC44-F7F8-4172-86D2-62D36EC54F25Q38117578-D2617AE2-D339-4424-8A3A-7461921619D9Q40295657-6DADB6A5-BB6F-4B2F-A293-AB8E286B68A8Q40321694-894D6400-CF43-4F33-8A32-B84F3DF70D2DQ40441842-1A741161-029F-416C-891C-CF4500F7CCA7Q40480821-2B0883AA-B003-4975-9DB3-97C3D0CE1B7AQ43016572-AD1A20DD-1D61-409C-BF59-93CE083AFE70Q43518544-9754208B-C3E7-482E-87F0-E8B1931B3DB3
P2860
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Oral versus intravenous antibi ...... analysis of randomized trials.
@ast
Oral versus intravenous antibi ...... analysis of randomized trials.
@en
type
label
Oral versus intravenous antibi ...... analysis of randomized trials.
@ast
Oral versus intravenous antibi ...... analysis of randomized trials.
@en
prefLabel
Oral versus intravenous antibi ...... analysis of randomized trials.
@ast
Oral versus intravenous antibi ...... analysis of randomized trials.
@en
P2093
P356
P1476
Oral versus intravenous antibi ...... analysis of randomized trials.
@en
P2093
Itsik Ben dor
Karla Soares-Weiser
Liat Vidal
P356
10.1093/JAC/DKH303
P407
P577
2004-06-16T00:00:00Z